Lack of increase in the serum thyroid-stimulating hormone level after intramuscular administration of recombinant human thyroid-stimulating hormone doses in a morbidly obese patient

Endocr Pract. 2011 Jul-Aug;17(4):657-8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Female
  • Humans
  • Injections, Intramuscular
  • Middle Aged
  • Obesity, Morbid / blood*
  • Obesity, Morbid / drug therapy*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use*
  • Thyrotropin / blood*

Substances

  • Recombinant Proteins
  • Thyrotropin